SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) September 15, 1997
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
300 Indian Springs Road, Indiana, Pennsylvania 15701
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
_________________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
On September 15, 1997, Biocontrol Technology, Inc.
(NASDAQ:BICO) announced today that as of September 12, 1997,
proxy returns for its Special Shareholders' Meeting on Monday,
September 22, 1997, have exceeded 82% of those eligible to vote,
and of those voting to date, over 92% have voted in favor of the
Company's proposal to increase its number of authorized shares.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired - Not
Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits-Press Release
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: September 15, 1997
BIOCONTROL TECHNOLOGY, INC
2275 Swallow Hill Road, Building 2500
Pittsburgh, PA 15220
Press Release
Release: Immediate
For More Information, Call:
Investors Media
Diane McQuaide
Susan Taylor
1.412.429.0673 phone
1.412.279.9455 phone
1.412.279.9690 fax
1.412.279.9447 fax
BIOCONTROL PROXY VOTES VERY SUPPORTIVE
Pittsburgh, PA - September 15, 1997 - Biocontrol
Technology, Inc. (Nasdaq:BICO) announced today that as of
September 12, 1997, proxy returns for its Special Shareholders'
Meeting on Monday, September 22, 1997, have exceeded 82% of those
eligible to vote, and of those voting to date, over 92% have
voted in favor of the Company's proposal to increase its number
of authorized shares.
The Company stressed that the meeting on September 22nd
is for shareholders only and photo identification and proof of
ownership as of the record date will be required for admittance.
Biocontrol Technology, Inc. has its corporate offices
in Pittsburgh, PA and is involved in the development and
manufacture of biomedical devices and environmental products.
